These data suggest that future studies of the role of CCN proteins in HHT can focus on potential matrix-dependent YAP1-inhibitory,-promoting, and-independent pathways regulating CTGF and CYR61 expression. The gene discussed is CCN2; the disease is hereditary hemorrhagic telangiectasia.